Published in Eur Neuropsychopharmacol on January 31, 2009
Projection-specific neuromodulation of medial prefrontal cortex neurons. J Neurosci (2010) 1.50
Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport (2009) 1.10
Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance. Neuropsychopharmacology (2013) 0.96
A new strategy for antidepressant prescription. Front Neurosci (2010) 0.96
Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1. Neuroscience (2009) 0.86
Reactivation in working memory: an attractor network model of free recall. PLoS One (2013) 0.83
Increased phosphorylation of extracellular signal-regulated kinase in the medial prefrontal cortex of the single-prolonged stress rats. Cell Mol Neurobiol (2009) 0.80
Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC. Neuropsychopharmacology (2014) 0.78
Chronic cocaine disrupts mesocortical learning mechanisms. Brain Res (2015) 0.78
Effect of dopaminergic D1 receptors on plasticity is dependent of serotoninergic 5-HT1A receptors in L5-pyramidal neurons of the prefrontal cortex. PLoS One (2015) 0.76
Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors. Psychopharmacology (Berl) (2015) 0.76
Binge-Like Alcohol Exposure during Adolescence Disrupts Dopaminergic Neurotransmission in the Adult Prelimbic Cortex. Neuropsychopharmacology (2016) 0.75
Modulation of Synaptic Plasticity in the Cortex Needs to Understand All the Players. Front Synaptic Neurosci (2017) 0.75
Interhemispheric regulation of the rat medial prefrontal cortical glutamate stress response: role of local GABA- and dopamine-sensitive mechanisms. Psychopharmacology (Berl) (2016) 0.75
The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex. J Neural Transm (Vienna) (2013) 0.75
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci (2007) 2.51
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest (2011) 2.25
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex (2004) 1.22
The hippocampal-prefrontal pathway: the weak link in psychiatric disorders? Eur Neuropsychopharmacol (2013) 1.20
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology (2008) 1.08
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem (2006) 1.03
Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J Comp Neurol (2005) 1.02
Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. Eur Arch Psychiatry Clin Neurosci (2009) 1.01
Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res (2004) 1.01
Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med (2005) 0.98
A new strategy for antidepressant prescription. Front Neurosci (2010) 0.96
Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. PLoS One (2010) 0.95
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) (2012) 0.94
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex. Behav Brain Res (2006) 0.90
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Phosphorylation of CREB and DARPP-32 during late LTP at hippocampal to prefrontal cortex synapses in vivo. Synapse (2007) 0.87
Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats. Neurobiol Learn Mem (2005) 0.87
Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol (2004) 0.87
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry (2006) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
Synergistic Regulation of Cytosolic Ca2+ Concentration by Adenosine and alpha1-Adrenergic Agonists in Mouse Striatal Astrocytes. Eur J Neurosci (1991) 0.86
Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res (2004) 0.86
Protection of stress-induced impairment of hippocampal/prefrontal LTP through blockade of glucocorticoid receptors: implication of MEK signaling. Exp Neurol (2008) 0.85
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain (2013) 0.85
Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res (2005) 0.85
Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology (Berl) (2007) 0.84
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
Acute stress induces contrasting changes in AMPA receptor subunit phosphorylation within the prefrontal cortex, amygdala and hippocampus. PLoS One (2010) 0.82
Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol (2009) 0.82
Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res (2009) 0.82
Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res (2010) 0.82
Nicotine use in schizophrenia and disinhibition. Psychiatry Res (2004) 0.82
Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord (2011) 0.82
Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol (2009) 0.82
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet (2006) 0.81
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord (2008) 0.81
Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet (2008) 0.81
The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord (2010) 0.81
Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia (2010) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
Endothelin-evoked Release of Arachidonic Acid from Mouse Astrocytes in Primary Culture. Eur J Neurosci (1992) 0.80
Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil (2014) 0.80
Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol (2011) 0.80
Exploring and visualizing multidimensional data in translational research platforms. Brief Bioinform (2016) 0.79
Don't be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory. Front Behav Neurosci (2013) 0.79
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol (2010) 0.79
Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res (2010) 0.79
Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res (2002) 0.79
Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr Res (2007) 0.78
Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores. Psychiatry Res (2012) 0.78
Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci (2011) 0.78
A step toward an objective quantification of subtle neurological signs in schizophrenia. Psychiatry Res (2012) 0.78
Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement. J Clin Exp Neuropsychol (2009) 0.78
Correlates between neurological soft signs and saccadic parameters in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.78
Cannabis use and schizophrenia. Am J Psychiatry (2005) 0.78
Effect of exposure to 1,800 MHz electromagnetic fields on heat shock proteins and glial cells in the brain of developing rats. Neurotox Res (2010) 0.78
Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation. Int J Neuropsychopharmacol (2010) 0.77
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav Brain Funct (2013) 0.77
Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia. Front Psychiatry (2010) 0.77
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) (2007) 0.77
Variable individual sensitivity to cannabis in patients with schizophrenia. Int J Neuropsychopharmacol (2010) 0.77
Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights. World J Biol Psychiatry (2011) 0.77
Episodic memory and impairment of an early encoding process in schizophrenia. Neuropsychology (2010) 0.77
Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis. Eur Addict Res (2011) 0.77
Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2003) 0.76
Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients. J Psychiatry Neurosci (2008) 0.76
Neurological soft signs in non-psychotic patients with cannabis dependence. Addict Biol (2010) 0.76
Hyperfrontality and hypoconnectivity during refreshing in schizophrenia. Psychiatry Res (2012) 0.76
Gender identity disorders and bipolar disorder associated with the ring Y chromosome. Am J Psychiatry (2007) 0.76
Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients. World J Biol Psychiatry (2011) 0.76
Cerebellum development and schizophrenia: an association study of the human homeogene Engrailed 2. Psychiatry Res (2004) 0.76
Postnatal effect of embryonic neurogenesis disturbance on reelin level in organotypic cultures of rat hippocampus. Brain Res (2006) 0.75
Comparing effects of perceptual and reflective repetition on subjective experience during later recognition memory. Conscious Cogn (2007) 0.75
[Principles of cognitive remediation in schizophrenia]. Bull Acad Natl Med (2011) 0.75
[Adaptation of a soft-signs scale to children with autism spectrum disorders]. Tunis Med (2009) 0.75